De-Sheng Weng

1.9k citations
33 papers · 1.6k indexed · h-index 23
Topics
Immune Cell Function and Interaction (15 papers)Immunotherapy and Immune Responses (13 papers)Cancer Immunotherapy and Biomarkers (12 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

De-Sheng Weng

33 papers receiving 1.6k citations

Peers

De-Sheng Weng
Comparison fields: 5 of 81
  • Oncology 846
  • Immunology 787
  • Molecular Biology 470
  • Cancer Research 210
  • Pulmonary and Respiratory Medicine 179
Replace Ji Yuan Wu with:
Ji Yuan Wu United States
Vera Levina United States
Jing-Jing Zhao China
Zhenbin Shen China
Hiromasa Kuroda Japan
Derya Duranyıldız Türkiye
Long‐Yun Ye China
Zhihai Peng China
Silke Reinartz Germany
Kathryn E. Beckermann United States
De-Sheng Weng relative to Ji Yuan Wu United States Ji Yuan Wu's profile →
Citations per field
00.5×4.7×
Ji Yuan Wu · 1×
Citations per year

Countries citing papers authored by De-Sheng Weng

Since Specialization
Citations

This map shows the geographic impact of De-Sheng Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De-Sheng Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De-Sheng Weng more than expected).

Fields of papers citing papers by De-Sheng Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De-Sheng Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De-Sheng Weng. The network helps show where De-Sheng Weng may publish in the future.

Co-authorship network of co-authors of De-Sheng Weng

This figure shows the co-authorship network connecting the top 25 collaborators of De-Sheng Weng. A scholar is included among the top collaborators of De-Sheng Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De-Sheng Weng. De-Sheng Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 51
2 15
3 27
4 24
5 4
6 22
7 3
8 51
9 23
10 28
11 77
12 93
13 56
14 77
15 3
16 68
17 9
18 127
19 16
20 43

About De-Sheng Weng

De-Sheng Weng is a scholar working on Immunology, Oncology and Biological Psychiatry, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (15 papers), Immunotherapy and Immune Responses (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). The work is most often cited by research in Biological Psychiatry (104 citations), Immunology (787 citations) and Oncology (846 citations). De-Sheng Weng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jian‐Chuan Xia, Jing-Jing Zhao, Qiu-Zhong Pan, Qi-Jing Wang, Ke Pan, Xiao Hai Li, Shan-Shan Jiang, Min-Shan Chen, Chang-Long Chen and Yong-Qiang Li. Their work appears in journals such as Scientific Reports, Clinical Cancer Research and Stem Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026